Explore by Category


MCRT Webcast: Where Are We? Where Are We Going? Assessing the State of Myeloma

MC ROUND TABLES - November 04, 2021

For our (foreseeable) final webcast-only Round Table of the pandemic, HealthTree Foundation President Jenny Ahlstrom engages in a wide-ranging discussion about ... Read More

MCRT Webcast: ASCO/EHA Meeting Review (Part 2)

MC ROUND TABLES - August 04, 2021

Three American-based myeloma specialists discuss the latest trends and studies in part two of the Myeloma Crowd Round Table Webcast on the highlights of the ann... Read More

ADVERTISEMENT
MCRT Webcast: ASCO/EHA Meeting Review (Part 1)

MC ROUND TABLES - July 23, 2021

The annual American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) meetings can be considered the “midterms” on t... Read More

MCRT Webcast: Treating Myeloma at the Dana-Farber Cancer Institute

MC ROUND TABLES - July 09, 2021

“It is an honor to come to work every day.  We’re inspired every day by our patients and driven to both care effectively for them and advance... Read More

ADVERTISEMENT
MCRT Webcast: New Myeloma Treatment Options for Relapsed/Refractory Patients

MC ROUND TABLES - June 30, 2021

Recently three new drug treatments have been added to the treatment arsenal for myeloma, two recently approved by the U.S. Food and Drug Administration (FDA) an... Read More

MCRT Webcast: BCMA and Other Targets

MC ROUND TABLES - May 22, 2021

B-cell maturation agent (BCMA), which is expressed on the surface of virtually all myeloma cells, has been called “the perfect target” by Dr. Nikhil... Read More

ADVERTISEMENT
MCRT Webcast: What’s Next? Decision-Making for Relapsed/Refractory Myeloma

MC ROUND TABLES - May 18, 2021

“For me, that is the reason why I like taking care of myeloma.  You’ve got to be a good listener and you’ve got to be a good historian.... Read More

MCRT Webcast: Fixing Disparities in Myeloma — The Key to Unlock Cures for All?

MC ROUND TABLES - May 09, 2021

People with sub-Saharan African ancestry have more than twice the risk of being diagnosed with myeloma than any other population.  According to the most re... Read More

ADVERTISEMENT
MCRT Webcast: American Society of Hematology Meeting Review (Part 2)

MC ROUND TABLES - March 17, 2021

The American Society of Hematology (ASH) meeting is the most important scientific meeting of the year for the hematology community.  The two part Myeloma C... Read More

MCRT Webcast: American Society of Hematology Meeting Review (Part 1)

MC ROUND TABLES - March 07, 2021

The annual American Society of Hematology (ASH) meeting is the most important scientific meeting of the year for the hematology community.  It is held annu... Read More

Learning About Myeloma: Myeloma Crowd Round Tables in 2020

MC ROUND TABLES - February 09, 2021

Sometimes we are compelled to learn about things that we never thought would be important in our lives.  Ask any myeloma patient or caregiver. That&rsqu... Read More

MCRT Webcast: Side Effects of Myeloma Treatment

MC ROUND TABLES - January 29, 2021

Side effects of various myeloma treatments—chemotherapy, bone-strengthening drugs, monoclonal antibodies, transplant—can be as bad or worse than the... Read More

MCRT Webcast: High-Risk Disease Essentials

MC ROUND TABLES - January 16, 2021

High-risk disease poses the most difficult questions in myeloma treatment.  Increasing knowledge about genetics provides information about which targets to... Read More


Thanks to our Myeloma Crowd Community sponsors:

.                         .       .